{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:20:55Z","timestamp":1790677255711,"version":"4.1.0"},"reference-count":263,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["ZY2022025"],"award-info":[{"award-number":["ZY2022025"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20210211"],"award-info":[{"award-number":["Y20210211"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"publisher","award":["XY2022005"],"award-info":[{"award-number":["XY2022005"]}],"id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007928","name":"Ningbo Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["2022 J047"],"award-info":[{"award-number":["2022 J047"]}],"id":[{"id":"10.13039\/501100007928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jconrel.2023.08.007","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T17:08:20Z","timestamp":1692119300000},"page":"568-591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems"],"prefix":"10.1016","volume":"361","author":[{"given":"Jiaojiao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaolong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunkuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jconrel.2023.08.007_bb0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-022-00604-y","article-title":"Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?","volume":"19","author":"Villablanca","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.jconrel.2023.08.007_bb0010","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jconrel.2023.05.007","article-title":"Wielding the double-edged sword: Redox drug delivery systems for inflammatory bowel disease","volume":"358","author":"Chen","year":"2023","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.12.044","article-title":"Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease","volume":"354","author":"Pu","year":"2023","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal cancer in inflammatory bowel disease: mechanisms and management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0035","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319899297","article-title":"Emerging treatments for inflammatory bowel disease","volume":"11","author":"Hazel","year":"2020","journal-title":"Ther. Adv. Chronic. Dis."},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101777","article-title":"Reproduction and pregnancy in inflammatory bowel disease - management and treatment based on current guidelines","volume":"50","author":"Szymanska","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"9853","key":"10.1016\/j.jconrel.2023.08.007_bb0045","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ordas","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0050","first-page":"1","article-title":"ECCO-ESCP consensus on surgery for Crohn\u2019s disease","volume":"12","author":"Bemelman","year":"2018","journal-title":"J. Crohns. Colitis."},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J. Crohns. Colitis."},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0060","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5009\/gnl16308","article-title":"Inflammatory bowel disease: updates on molecular targets for biologics","volume":"11","author":"Katsanos","year":"2017","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0065","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.gtc.2020.08.002","article-title":"Biologic therapy for ulcerative colitis","volume":"49","author":"Bhattacharya","year":"2020","journal-title":"Gastroenterol. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000458006","article-title":"Current and future targets for mucosal healing in inflammatory bowel disease","volume":"33","author":"Atreya","year":"2017","journal-title":"Visc Med"},{"issue":"7","key":"10.1016\/j.jconrel.2023.08.007_bb0075","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/den.13863","article-title":"The endoscopic diagnosis of mucosal healing and deep remission in inflammatory bowel disease","volume":"33","author":"Moriichi","year":"2020","journal-title":"Dig. Endosc."},{"issue":"27","key":"10.1016\/j.jconrel.2023.08.007_bb0080","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.3748\/wjg.v25.i27.3572","article-title":"Mucosal healing progression after acute colitis in mice","volume":"25","author":"Vidal-Lletjos","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12897","article-title":"Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases","volume":"92","author":"Zhang","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fimmu.2017.00022","article-title":"Applications of genetically modified immunobiotics with high immunoregulatory capacity for treatment of inflammatory bowel diseases","volume":"8","author":"Shigemori","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0095","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ibd.21316","article-title":"Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing","volume":"17","author":"Krishnan","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejps.2016.05.015","article-title":"Type I collagen and its daughter peptides for targeting mucosal healing in ulcerative colitis: a new treatment strategy","volume":"91","author":"Ramadass","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2018.08.021","article-title":"TNFalpha gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis","volume":"287","author":"Xiao","year":"2018","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2023.08.007_bb0110","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.apsb.2021.04.001","article-title":"Oral delivery of proteins and peptides: challenges, status quo and future perspectives","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2017.05.008","article-title":"Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanoparticles reduces inflammation in an ex vivo osteoarthritis model","volume":"258","author":"McMasters","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fbioe.2020.00265","article-title":"Engineered probiotics for detection and treatment of inflammatory intestinal diseases","volume":"8","author":"Barra","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"7","key":"10.1016\/j.jconrel.2023.08.007_bb0125","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/1751-2980.12614","article-title":"Colon capsule endoscopy for inflammatory bowel disease","volume":"19","author":"Li","year":"2018","journal-title":"J. Dig. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-011-0104-6","article-title":"Targeting leukocyte migration and adhesion in Crohn\u2019s disease and ulcerative colitis","volume":"20","author":"Thomas","year":"2012","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0135","first-page":"208","article-title":"Anti-integrin therapy for inflammatory bowel disease","volume":"116","author":"Iijima","year":"2019","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0140","first-page":"1","article-title":"Anti-MADCAM therapy for ulcerative colitis","author":"Picardo","year":"2019","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"9","key":"10.1016\/j.jconrel.2023.08.007_bb0145","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrgastro.2015.135","article-title":"Biologic agents for IBD: practical insights","volume":"12","author":"Danese","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.jconrel.2023.08.007_bb0150","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/ecco-jcc\/jjaa035","article-title":"Immunological variables associated with clinical and endoscopic response to vedolizumab in patients with inflammatory bowel diseases","volume":"14","author":"Coletta","year":"2020","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/CEG.S293272","article-title":"Anti-integrins for the treatment of inflammatory bowel disease: current evidence and perspectives","volume":"14","author":"Gubatan","year":"2021","journal-title":"Clin. Exp. Gastroenterol."},{"issue":"7","key":"10.1016\/j.jconrel.2023.08.007_bb0160","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/jcph.1590","article-title":"Population pharmacokinetics and pharmacodynamics of ontamalimab (SHP647), a fully human monoclonal antibody against mucosal addressin cell adhesion molecule-1 (MAdCAM-1), in patients with ulcerative colitis or Crohn\u2019s disease","volume":"60","author":"Wang","year":"2020","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjad088","article-title":"Differential effects of ontamalimab versus vedolizumab on immune cell trafficking in intestinal inflammation and IBD","author":"Schulze","year":"2023","journal-title":"J. Crohns. Colitis."},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0170","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2967\/jnumed.115.165795","article-title":"99mTc-CXCL8 SPECT to monitor disease activity in inflammatory bowel disease","volume":"57","author":"Aarntzen","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"11","key":"10.1016\/j.jconrel.2023.08.007_bb0175","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1097\/TP.0000000000000741","article-title":"A phase I\/II trial of the interleukin-6 receptor-specific humanized monoclonal (tocilizumab) + intravenous immunoglobulin in difficult to desensitize patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jconrel.2023.08.007_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005111","article-title":"COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis","volume":"10","author":"Holmstroem","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cyto.2016.04.012","article-title":"Neutralization of IL-6 and TNF-alpha ameliorates intestinal permeability in DSS-induced colitis","volume":"83","author":"Xiao","year":"2016","journal-title":"Cytokine"},{"issue":"13","key":"10.1016\/j.jconrel.2023.08.007_bb0190","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","article-title":"Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0195","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.gtc.2017.05.013","article-title":"Ustekinumab and anti-interleukin-23 agents in Crohn\u2019s disease","volume":"46","author":"Deepak","year":"2017","journal-title":"Gastroenterol. Clin. N. Am."},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/13543784.2019.1597053","article-title":"Expert opinion on interleukin-12\/23 and interleukin-23 antagonists as potential therapeutic options for the treatment of inflammatory bowel disease","volume":"28","author":"Wong","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb0205","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41551-020-0556-3","article-title":"De novo development of proteolytically resistant therapeutic peptides for oral administration","volume":"4","author":"Kong","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb0210","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.autrev.2019.03.012","article-title":"The role of interleukin-13 in chronic inflammatory intestinal disorders","volume":"18","author":"Giuffrida","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.651415","article-title":"Novel and emerging therapies for inflammatory bowel disease","volume":"12","author":"Al-Bawardy","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.jconrel.2023.08.007_bb0220","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/jcmm.13428","article-title":"IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109932","article-title":"Interleukin-35 and Interleukin-37 anti-Inflammatory effect on inflammatory bowel disease: application of non-coding RNAs in IBD therapy","volume":"117","author":"Reza Lahimchi","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.gastro.2018.03.058","article-title":"In inflamed intestinal tissues and epithelial cells, interleukin 22 signaling increases expression of H19 long noncoding RNA, which promotes mucosal regeneration","volume":"155","author":"Geng","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0235","doi-asserted-by":"crossref","first-page":"113828","DOI":"10.1016\/j.addr.2021.113828","article-title":"Drug delivery to the inflamed intestinal mucosa- targeting technologies and human cell culture models for better therapies of IBD","volume":"175","author":"Olga","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.612830","article-title":"Vedolizumab: potential mechanisms of action for reducing pathological inflammation in inflammatory bowel diseases","volume":"9","author":"Luzentales-Simpson","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.jconrel.2023.08.007_bb0245","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1007\/s12325-020-01366-2","article-title":"Etrolizumab for the treatment of ulcerative colitis and Crohn\u2019s disease: an overview of the phase 3 clinical program","volume":"37","author":"Sandborn","year":"2020","journal-title":"Adv. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0250","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1053\/j.gastro.2018.11.035","article-title":"Efficacy and safety of abrilumab in a randomized, placebo-controlled trial for moderate-to-severe ulcerative colitis","volume":"156","author":"Sandborn","year":"2019","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jconrel.2023.08.007_bb0255","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2468-1253(22)00022-X","article-title":"AJM300 (carotegrast methyl), an oral antagonist of alpha4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"7","author":"Matsuoka","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb0260","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/ecco-jcc\/jjw036","article-title":"AVX-470, an orally delivered anti-tumour necrosis factor antibody for treatment of active ulcerative colitiss: results of a first-in-human trial","volume":"10","author":"Harris","year":"2016","journal-title":"J. Crohns. Colitis."},{"issue":"13","key":"10.1016\/j.jconrel.2023.08.007_bb0265","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1905725","article-title":"Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2023.08.007_bb0270","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.cgh.2020.01.008","article-title":"First- and second-line pharmacotherapies for patients with moderate to severely active ulcerative colitis: an updated network meta-analysis","volume":"18","author":"Singh","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0275","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/14712598.2020.1697227","article-title":"Anti-interleukin-23 agents for the treatment of ulcerative colitis","volume":"20","author":"Hanzel","year":"2020","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0280","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ecco-jcc\/jjv224","article-title":"Eldelumab [santi-IP-10] induction therapy for ulcerative colitis: a randomised, placebo-controlled, phase 2b study","volume":"10","author":"Sandborn","year":"2016","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0285","first-page":"119","article-title":"CCR9 antagonism: potential in the treatment of Inflammatory bowel disease","volume":"8","author":"Wendt","year":"2015","journal-title":"Clin. Exp. Gastroenterol."},{"issue":"20","key":"10.1016\/j.jconrel.2023.08.007_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201800069","article-title":"Dual-crosslinked amorphous polysaccharide hydrogels based on chitosan\/alginate for wound healing applications","volume":"39","author":"Hu","year":"2018","journal-title":"Macromol. Rapid Commun."},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb0295","first-page":"635","article-title":"Design, expression, and renaturation of a lesion-targeted recombinant epidermal growth factor-von Willebrand factor fusion protein: efficacy in an animal model of experimental colitis","volume":"6","author":"Hall","year":"2000","journal-title":"Int. J. Mol. Med."},{"issue":"8758","key":"10.1016\/j.jconrel.2023.08.007_bb0300","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0140-6736(91)90042-N","article-title":"Epidermal growth factor in necrotising enteritis","volume":"338","author":"Sullivan","year":"1991","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2023.08.007_bb0305","first-page":"S78","article-title":"Gastric ulcer treatment with intravenous human epidermal growth factor: a double-blind controlled clinical study","volume":"9","author":"Itoh","year":"1994","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb0310","first-page":"409","article-title":"Oral human recombinant epidermal growth factor in the treatment of patients with duodenal ulcer","volume":"88","author":"Haedo","year":"1996","journal-title":"Rev. Esp. Enferm. Dig."},{"issue":"10","key":"10.1016\/j.jconrel.2023.08.007_bb0315","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1080\/003655200451126","article-title":"A multicenter, randomized, double-blind clinical trial examining the effect of oral human recombinant epidermal growth factor on the healing of duodenal ulcers","volume":"35","author":"Palomino","year":"2000","journal-title":"Scand. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0320","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJMoa013136","article-title":"Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis","volume":"349","author":"Sinha","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb0325","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.jconrel.2023.08.007_bb0330","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbadis.2009.06.004","article-title":"TGF-beta and fibrosis in different organs - molecular pathway imprints","volume":"1792","author":"Pohlers","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0335","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/gast.1996.v110.pm8613031","article-title":"Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease","volume":"110","author":"Babyatsky","year":"1996","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jconrel.2023.08.007_bb0340","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/jcp.10275","article-title":"Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats","volume":"196","author":"Maric","year":"2003","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.jconrel.2023.08.007_bb0345","doi-asserted-by":"crossref","first-page":"G1151","DOI":"10.1152\/ajpgi.00244.2011","article-title":"BMP signaling in rats with TNBS-induced colitis following BMP7 therapy","volume":"302","author":"Maric","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0350","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00054725-199902000-00007","article-title":"Growth factors in inflammatory bowel disease","volume":"5","author":"Beck","year":"1999","journal-title":"Inflamm. Bowel Dis."},{"issue":"7","key":"10.1016\/j.jconrel.2023.08.007_bb0355","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/002215549704500710","article-title":"Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues","volume":"45","author":"Hughes","year":"1997","journal-title":"J. Histochem. Cytochem. Off. J. Histochem. Soc."},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0360","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/gast.2002.36041","article-title":"A novel human fibroblast growth factor treats experimental intestinal inflammation","volume":"123","author":"Jeffers","year":"2002","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb0365","first-page":"933","article-title":"Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality","volume":"58","author":"Farrell","year":"1998","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.jconrel.2023.08.007_bb0370","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1158\/1078-0432.CCR-04-1118","article-title":"Phase I\/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation","volume":"10","author":"Freytes","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.jconrel.2023.08.007_bb0375","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1046\/j.1365-2036.2003.01589.x","article-title":"Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial","volume":"17","author":"Sandborn","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2023.08.007_bb0380","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/jpet.111.183665","article-title":"Molecular mechanisms of basic fibroblast growth factor effect on healing of ulcerative colitis in rats","volume":"339","author":"Paunovic","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0385","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2005.01.006","article-title":"Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis","volume":"128","author":"Matsuura","year":"2005","journal-title":"Gastroenterology"},{"issue":"77","key":"10.1016\/j.jconrel.2023.08.007_bb0390","first-page":"1373","article-title":"Basic fibroblast growth factor enema improves experimental colitis in rats","volume":"54","author":"Kojima","year":"2007","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41419-022-04504-6","article-title":"Pathological and therapeutic roles of bioactive peptide trefoil factor 3 in diverse diseases: recent progress and perspective","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb0400","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11894-010-0131-2","article-title":"Intestinal goblet cells and mucins in health and disease: recent insights and progress","volume":"12","author":"Kim","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124150","article-title":"Oyster polysaccharides relieve DSS-induced colitis via anti-inflammatory and maintaining the physiological hypoxia","volume":"238","author":"Jiang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0410","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.regpep.2004.09.007","article-title":"Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat","volume":"126","author":"Poulsen","year":"2005","journal-title":"Regul. Pept."},{"issue":"11","key":"10.1016\/j.jconrel.2023.08.007_bb0415","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1365-2036.2005.02436.x","article-title":"Trial of trefoil factor 3 enemas, in combination with oral 5-aminosalicylic acid, for the treatment of mild-to-moderate left-sided ulcerative colitis","volume":"21","author":"Mahmood","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0420","doi-asserted-by":"crossref","first-page":"8298192","DOI":"10.1155\/2019\/8298192","article-title":"Treatment with molgramostim (recombinant human granulocyte-macrophage colony stimulating factor, Rhugm-Csf, Mielogen) and lenograstim (granulocyte-colony stimulating factor) improves experimental colitis in rats","volume":"2019","author":"Papalois","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"2-3","key":"10.1016\/j.jconrel.2023.08.007_bb0425","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000074517","article-title":"An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease","volume":"68","author":"Dejaco","year":"2003","journal-title":"Digestion"},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0430","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2036.2005.02287.x","article-title":"An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn\u2019s disease","volume":"21","author":"Korzenik","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"22","key":"10.1016\/j.jconrel.2023.08.007_bb0435","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM200006013422203","article-title":"A preliminary study of growth hormone therapy for Crohn\u2019s disease","volume":"342","author":"Slonim","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb0440","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/mi.2014.21","article-title":"Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis","volume":"7","author":"Ahmad","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"11","key":"10.1016\/j.jconrel.2023.08.007_bb0445","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/1440-1681.12646","article-title":"Hydrogen peroxide scavenger, catalase, alleviates ion transport dysfunction in murine colitis","volume":"43","author":"Barrett","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120753","article-title":"Oral delivery of antioxidant enzymes for effective treatment of inflammatory disease","volume":"271","author":"Zeng","year":"2021","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2023.08.007_bb0455","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.phrs.2012.04.006","article-title":"Exogenous alkaline phosphatase treatment complements endogenous enzyme protection in colonic inflammation and reduces bacterial translocation in rats","volume":"66","author":"Martinez-Moya","year":"2012","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb0460","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1053\/j.gastro.2012.07.016","article-title":"Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine","volume":"143","author":"Monteleone","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0465","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-1103-6","article-title":"Prediction of anti-inflammatory proteins\/peptides: an insilico approach","volume":"15","author":"Gupta","year":"2017","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0470","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI110748","article-title":"Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes","volume":"71","author":"Dharmsathaphorn","year":"1983","journal-title":"J. Clin. Invest."},{"issue":"25","key":"10.1016\/j.jconrel.2023.08.007_bb0475","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.2217\/nnm-2020-0280","article-title":"Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule","volume":"15","author":"Dulari","year":"2020","journal-title":"Nanomedicine (London)"},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0480","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ibd.20334","article-title":"Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease","volume":"14","author":"Kannengiesser","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"issue":"15","key":"10.1016\/j.jconrel.2023.08.007_bb0485","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1021\/acsami.7b00936","article-title":"Peptide receptor-targeted fluorescent probe: visualization and discrimination between chronic and acute ulcerative colitis","volume":"9","author":"Zeng","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0490","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2007.10.026","article-title":"PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation","volume":"134","author":"Dalmasso","year":"2008","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jconrel.2023.08.007_bb0495","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nrrheum.2013.126","article-title":"Annexin A1: potential for glucocorticoid sparing in RA","volume":"9","author":"Yang","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"11","key":"10.1016\/j.jconrel.2023.08.007_bb0500","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/nm786","article-title":"Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor","volume":"8","author":"Perretti","year":"2002","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0505","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI76693","article-title":"Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair","volume":"125","author":"Leoni","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.jconrel.2023.08.007_bb0510","doi-asserted-by":"crossref","first-page":"1900610","DOI":"10.1002\/advs.201900610","article-title":"A proresolving peptide nanotherapy for site-specific treatment of inflammatory bowel disease by regulating proinflammatory microenvironment and gut microbiota","volume":"6","author":"Li","year":"2019","journal-title":"Adv. Sci. (Weinh)"},{"issue":"24","key":"10.1016\/j.jconrel.2023.08.007_bb0515","doi-asserted-by":"crossref","first-page":"10288","DOI":"10.1074\/jbc.M117.779215","article-title":"An engineered cyclic peptide alleviates symptoms of inflammation in a murine model of inflammatory bowel disease","volume":"292","author":"Cobos Caceres","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0520","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3389\/fphar.2020.00593","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline mitigates experimental colitis through inhibition of intestinal mucosal inflammatory responses via MEK-ERK signaling","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb0525","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.4049\/jimmunol.0900863","article-title":"Helicobacter pylori Hp(2-20) promotes migration and proliferation of gastric epithelial cells by interacting with formyl peptide receptors in vitro and accelerates gastric mucosal healing in vivo","volume":"183","author":"de Paulis","year":"2009","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2023.08.007_bb0530","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1177\/2050640618793564","article-title":"Peptide Hp(2-20) accelerates healing of TNBS-induced colitis in the rat","volume":"6","author":"Gravina","year":"2018","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0535","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4161\/gmic.19245","article-title":"Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases","volume":"3","author":"Yan","year":"2012","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170364","volume":"132","author":"Chulkina","year":"2020","journal-title":"Peptides"},{"issue":"18","key":"10.1016\/j.jconrel.2023.08.007_bb0545","doi-asserted-by":"crossref","first-page":"18522","DOI":"10.18632\/aging.103825","article-title":"GPA peptide inhibits NLRP3 inflammasome activation to ameliorate colitis through AMPK pathway","volume":"12","author":"Deng","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0550","doi-asserted-by":"crossref","first-page":"4964202","DOI":"10.1155\/2020\/4964202","article-title":"GPA peptide-induced Nur77 localization at mitochondria inhibits inflammation and oxidative stress through activating autophagy in the intestine","volume":"2020","author":"Deng","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.jconrel.2023.08.007_bb0555","first-page":"530","article-title":"Therapeutic efficacy of a mutant of keratinocyte growth factor-2 on trinitrobenzene sulfonic acid-induced rat model of Crohn\u2019s disease","volume":"8","author":"Wang","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2023.08.007_bb0560","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/ibd\/izz097","article-title":"A manganese-superoxide dismutase from thermus thermophilus HB27 suppresses inflammatory responses and alleviates experimentally induced colitis","volume":"25","author":"Sheng","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0565","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/anie.202010714","article-title":"Ligand-dependent activity engineering of glutathione peroxidase-mimicking MIL-47(V) metal-organic framework nanozyme for therapy","volume":"60","author":"Wu","year":"2021","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"11","key":"10.1016\/j.jconrel.2023.08.007_bb0570","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1021\/acs.molpharmaceut.7b00452","article-title":"Vasoactive intestinal peptide nanomedicine for the management of inflammatory bowel disease","volume":"14","author":"Jayawardena","year":"2017","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb0575","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1172\/JCI44031","article-title":"Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism","volume":"121","author":"Yan","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.934852","article-title":"Peptides derived from hookworm anti-inflammatory proteins suppress inducible colitis in mice and inflammatory cytokine production by human cells","volume":"9","author":"Cobos","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0585","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/IJN.S187854","article-title":"An anti-inflammatory peptide and brain-derived neurotrophic factor-modified hyaluronan-methylcellulose hydrogel promotes nerve regeneration in rats with spinal cord injury","volume":"14","author":"He","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"11","key":"10.1016\/j.jconrel.2023.08.007_bb0590","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nmat2859","article-title":"Orally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestines","volume":"9","author":"Wilson","year":"2010","journal-title":"Nat. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb0595","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.01.056","article-title":"Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice","volume":"146","author":"Xiao","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0600","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/jpet.102.036053","article-title":"Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27\/beta2 microglobulin transgenic rat model","volume":"302","author":"Bowen-Yacyshyn","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0605","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.gastro.2016.09.005","article-title":"Rectal delivery of a DNAzyme That specifically blocks the transcription factor GATA3 and reduces colitis in mice","volume":"152","author":"Popp","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0610","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/mt.2011.290","article-title":"Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn\u2019s disease","volume":"20","author":"Monteleone","year":"2012","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2023.08.007_bb0615","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ibd.23019","article-title":"Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity","volume":"19","author":"Musch","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"issue":"7","key":"10.1016\/j.jconrel.2023.08.007_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158967","article-title":"Pivotal role of carbohydrate sulfotransferase 15 in fibrosis and mucosal healing in mouse colitis","volume":"11","author":"Suzuki","year":"2016","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.jconrel.2023.08.007_bb0625","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/gt.2008.67","article-title":"Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease","volume":"15","author":"Bhavsar","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0630","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/IJN.S286392","article-title":"Oral nanoparticles of SNX10-shRNA plasmids ameliorate mouse colitis","volume":"16","author":"Bao","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0635","first-page":"21 (2)","article-title":"Topical therapy with antisense tumor necrosis factor alpha using novel beta-glucan-based drug delivery system ameliorates intestinal inflammation","author":"Sakisaka","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0640","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2018.10.009","article-title":"Local delivery of macromolecules to treat diseases associated with the colon","volume":"136-137","author":"Bak","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.jconrel.2023.08.007_bb0645","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.15710","article-title":"Combination therapy for ulcerative colitis: orally targeted nanoparticles prevent mucosal damage and relieve inflammation","volume":"6","author":"Xiao","year":"2016","journal-title":"Theranostics"},{"issue":"14","key":"10.1016\/j.jconrel.2023.08.007_bb0650","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3685","article-title":"Preparation and characterization of ginger lipid-derived nanoparticles for colon-targeted siRNA delivery","volume":"10","author":"Sung","year":"2020","journal-title":"Bio Protoc"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0655","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fphar.2019.00314","article-title":"Oligonucleotides-A novel promising therapeutic option for IBD","volume":"10","author":"Scarozza","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0660","first-page":"47","article-title":"Therapeutic oligonucleotides for patients with inflammatory bowel diseases","volume":"14","author":"Marafini","year":"2020","journal-title":"Biologics"},{"issue":"2","key":"10.1016\/j.jconrel.2023.08.007_bb0665","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1053\/j.gastro.2021.04.064","article-title":"TGF-beta signaling in liver, pancreas, and gastrointestinal diseases and cancer","volume":"161","author":"Gough","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104757","article-title":"TGF-beta activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseases","volume":"155","author":"Marafini","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2023.08.007_bb0675","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/ecco-jcc\/jjw143","article-title":"Phase 1 clinical study of siRNA targeting carbohydrate sulphotransferase 15 in Crohn\u2019s disease patients with active mucosal lesions","volume":"11","author":"Suzuki","year":"2017","journal-title":"J. Crohns. Colitis."},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb0680","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/sctm.17-0305","article-title":"Mesenchymal stem cells (MSC) derived from induced pluripotent stem cells (iPSC) equivalent to adipose-derived MSC in promoting intestinal healing and microbiome normalization in mouse inflammatory bowel disease model","volume":"7","author":"Soontararak","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119905","article-title":"Fabrication of polyphenol-incorporated anti-inflammatory hydrogel via high-affinity enzymatic crosslinking for wet tissue adhesion","volume":"242","author":"Kim","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0690","article-title":"Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: therapeutic outlook for inflammatory and degenerative diseases","volume":"11","author":"Dabrowska","year":"2020","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.jconrel.2023.08.007_bb0695","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.3748\/wjg.v21.i16.4779","article-title":"Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease","volume":"21","author":"Chinnadurai","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.jconrel.2023.08.007_bb0700","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/ecco-jcc\/jjaa079","article-title":"Cell therapy with mesenchymal stem cells induces an innate immune memory response that attenuates experimental colitis in the long-term","volume":"14","author":"Lopez-Santalla","year":"2020","journal-title":"J. Crohns. Colitis."},{"issue":"8","key":"10.1016\/j.jconrel.2023.08.007_bb0705","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ecco-jcc\/jjw047","article-title":"Intraluminal injection of mesenchymal stromal cells in spheroids attenuates experimental colitis","volume":"10","author":"Molendijk","year":"2016","journal-title":"J. Crohns. Colitis."},{"issue":"17","key":"10.1016\/j.jconrel.2023.08.007_bb0710","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.7150\/thno.45434","article-title":"IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization","volume":"10","author":"Cao","year":"2020","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0715","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1242\/dev.097386","article-title":"How to make an intestine","volume":"141","author":"Wells","year":"2014","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0720","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-0033-1350059","article-title":"Amniotic fluid stem cells prevent development of ascites in a neonatal rat model of necrotizing enterocolitis","volume":"24","author":"Zani","year":"2014","journal-title":"Eur. J. Pediatr. Surg."},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0725","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nm.2695","article-title":"Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5(+) stem cell","volume":"18","author":"Yui","year":"2012","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.jconrel.2023.08.007_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081127","article-title":"Tailored hydrogels as delivery platforms for conditioned medium from mesenchymal stem cells in a model of acute colitis in mice","volume":"13","author":"Sendon-Lago","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0735","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2018.06.021","article-title":"Bioresponsive drug delivery systems in intestinal inflammation: state-of-the-art and future perspectives","volume":"146","author":"Kotla","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0740","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOG.0000000000000327","article-title":"Mesenchymal stem\/stromal cell therapy for inflammatory bowel disease: an updated review with maintenance of remission","volume":"33","author":"Dave","year":"2017","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2023.08.007_bb0745","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000449091","article-title":"Mesenchymal stromal cell therapy in Crohn\u2019s disease","volume":"35","author":"Forbes","year":"2017","journal-title":"Dig. Dis."},{"issue":"12","key":"10.1016\/j.jconrel.2023.08.007_bb0750","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.dld.2011.07.021","article-title":"Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn\u2019s disease","volume":"43","author":"Clerici","year":"2011","journal-title":"Dig. Liver Dis."},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb0755","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood-2002-07-2122","article-title":"High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease","volume":"101","author":"Burt","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jconrel.2023.08.007_bb0760","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","article-title":"Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn\u2019s disease: results of a phase I study","volume":"59","author":"Duijvestein","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.604021","article-title":"Human umbilical cord blood derived-mesenchymal stem cells alleviate dextran sulfate sodium-induced colitis by increasing regulatory T cells in mice","volume":"8","author":"Li","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0770","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00253-019-10259-6","article-title":"Combination of probiotics with different functions alleviate DSS-induced colitis by regulating intestinal microbiota, IL-10, and barrier function","volume":"104","author":"Wang","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0775","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.581778","article-title":"Bacteriocins from LAB and other alternative approaches for the control of clostridium and clostridiodes related gastrointestinal colitis","volume":"8","author":"Todorov","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"24","key":"10.1016\/j.jconrel.2023.08.007_bb0780","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.3748\/wjg.v22.i24.5505","article-title":"Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update","volume":"22","author":"Scaldaferri","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"16","key":"10.1016\/j.jconrel.2023.08.007_bb0785","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125166","article-title":"Nononcogenic restoration of the intestinal barrier by E. coli-delivered human EGF","volume":"4","author":"Yu","year":"2019","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.jconrel.2023.08.007_bb0790","doi-asserted-by":"crossref","DOI":"10.3390\/nu15071566","article-title":"The role of genetically engineered probiotics for treatment of inflammatory bowel disease: a systematic review","volume":"15","author":"Zhang","year":"2023","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.jconrel.2023.08.007_bb0795","doi-asserted-by":"crossref","DOI":"10.3390\/ph14121211","article-title":"Exploiting the metabolism of the gut microbiome as a vehicle for targeted drug delivery to the colon","volume":"14","author":"Bakshi","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0800","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12934-015-0198-4","article-title":"Serine protease inhibitors protect better than IL-10 and TGF-beta anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci","volume":"14","author":"Bermudez-Humaran","year":"2015","journal-title":"Microb. Cell Factories"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0805","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12967-018-1441-7","article-title":"Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice","volume":"16","author":"Zhang","year":"2018","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.jconrel.2023.08.007_bb0810","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0815","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/mi.2009.116","article-title":"lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis","volume":"3","author":"Vandenbroucke","year":"2010","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2023.08.007_bb0820","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/mt.2014.222","article-title":"Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli","volume":"23","author":"Spisni","year":"2015","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2023.08.007_bb0825","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1099\/jmm.0.000197","article-title":"Oral delivery of Bifidobacterium longum expressing alpha-melanocyte-stimulating hormone to combat ulcerative colitis","volume":"65","author":"Wei","year":"2016","journal-title":"J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0830","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AEM.03296-13","article-title":"Genetically engineered immunomodulatory Streptococcus thermophilus strains producing antioxidant enzymes exhibit enhanced anti-inflammatory activities","volume":"80","author":"Del Carmen","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0835","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12934-022-01840-2","article-title":"A recombinant Bifidobacterium bifidum BGN4 strain expressing the streptococcal superoxide dismutase gene ameliorates inflammatory bowel disease","volume":"21","author":"Kang","year":"2022","journal-title":"Microb. Cell Factories"},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0840","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.xphs.2021.11.024","article-title":"Oxidation and deamidation of monoclonal antibody products: potential impact on stability, biological activity, and efficacy","volume":"111","author":"Gupta","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"43","key":"10.1016\/j.jconrel.2023.08.007_bb0845","doi-asserted-by":"crossref","first-page":"39459","DOI":"10.1021\/acsami.9b12723","article-title":"Dual thermo- and pH-responsive behavior of double zwitterionic graft copolymers for suppression of protein aggregation and protein release","volume":"11","author":"Zhao","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0850","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/10717544.2017.1333173","article-title":"Temperature-sensitive heparin-modified poloxamer hydrogel with affinity to KGF facilitate the morphologic and functional recovery of the injured rat uterus","volume":"24","author":"Xu","year":"2017","journal-title":"Drug. Deliv."},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0855","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/156720112801323062","article-title":"Foam preparations for the treatment of ulcerative colitis","volume":"9","author":"Loew","year":"2012","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0860","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3389\/fphar.2019.01196","article-title":"Physiological and pharmaceutical considerations for rectal drug formulations","volume":"10","author":"Hua","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.jconrel.2023.08.007_bb0865","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/wound.2012.0370","article-title":"Proteases and delayed wound healing","volume":"2","author":"McCarty","year":"2013","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb0870","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF02974039","article-title":"Effect of protease inhibitors on degradation of recombinant human epidermal growth factor in skin tissue","volume":"20","author":"Ryou","year":"1997","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0875","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2020.04.014","article-title":"Photo-responsive supramolecular hyaluronic acid hydrogels for accelerated wound healing","volume":"323","author":"Zhao","year":"2020","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.jconrel.2023.08.007_bb0880","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1039\/D0BM00603C","article-title":"Visible light mediated PVA-tyramine hydrogels for covalent incorporation and tailorable release of functional growth factors","volume":"8","author":"Atienza-Roca","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0885","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.actbio.2019.01.029","article-title":"Hyaluronan\/collagen hydrogels containing sulfated hyaluronan improve wound healing by sustained release of heparin-binding EGF-like growth factor","volume":"86","author":"Thones","year":"2019","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0890","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1039\/C9BM00668K","article-title":"Biomimetic proteoglycan nanoparticles for growth factor immobilization and delivery","volume":"8","author":"Zandi","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0895","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2017.02.025","article-title":"Silk-elastinlike protein polymers enhance the efficacy of a therapeutic glycosaminoglycan for prophylactic treatment of radiation-induced proctitis","volume":"263","author":"Jensen","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0900","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.addr.2019.04.007","article-title":"Thiolated polymers: Bioinspired polymers utilizing one of the most important bridging structures in nature","volume":"151-152","author":"Leichner","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0905","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbrc.2019.08.082","article-title":"Highly sulfated hyaluronic acid maintains human induced pluripotent stem cells under feeder-free and bFGF-free conditions","volume":"518","author":"Miura","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2023.08.007_bb0910","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.641529","article-title":"Timely supplementation of hydrogels containing sulfated or unsulfated chondroitin and hyaluronic acid affects mesenchymal stromal cells commitment toward chondrogenic differentiation","volume":"9","author":"Alessio","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb0915","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1021\/jacs.7b12776","article-title":"High drug loading and sub-quantitative loading efficiency of polymeric micelles driven by donor-receptor coordination interactions","volume":"140","author":"Lv","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.jconrel.2023.08.007_bb0920","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.biomaterials.2013.10.028","article-title":"The combined effects of size and surface chemistry on the accumulation of boronic acid-rich protein nanoparticles in tumors","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb0925","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1021\/cr300222d","article-title":"Cation-pi interaction: its role and relevance in chemistry, biology, and material science","volume":"113","author":"Mahadevi","year":"2013","journal-title":"Chem. Rev."},{"issue":"41","key":"10.1016\/j.jconrel.2023.08.007_bb0930","doi-asserted-by":"crossref","first-page":"12596","DOI":"10.1002\/anie.201600547","article-title":"The cation-pi Interaction in small-molecule catalysis","volume":"55","author":"Kennedy","year":"2016","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb0935","doi-asserted-by":"crossref","first-page":"eaaw8922","DOI":"10.1126\/sciadv.aaw8922","article-title":"A boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing","volume":"5","author":"Liu","year":"2019","journal-title":"Sci. Adv."},{"issue":"36","key":"10.1016\/j.jconrel.2023.08.007_bb0940","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1002\/anie.202002089","article-title":"Polyphenol-mediated assembly of proteins for engineering functional materials","volume":"59","author":"Han","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb0945","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.biomaterials.2008.10.053","article-title":"The development of a nanocrystalline apatite reinforced crosslinked hyaluronic acid-tyramine composite as an injectable bone cement","volume":"30","author":"Pek","year":"2009","journal-title":"Biomaterials"},{"issue":"29","key":"10.1016\/j.jconrel.2023.08.007_bb0950","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1016\/j.biomaterials.2013.06.005","article-title":"Covalent incorporation of non-chemically modified gelatin into degradable PVA-tyramine hydrogels","volume":"34","author":"Lim","year":"2013","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.jconrel.2023.08.007_bb0955","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1089\/ten.tea.2009.0764","article-title":"Enzymatically crosslinked dextran-tyramine hydrogels as injectable scaffolds for cartilage tissue engineering","volume":"16","author":"Jin","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0960","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jconrel.2021.04.026","article-title":"Oral delivery of micro\/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: chsallenges, advances and future perspectives","volume":"334","author":"Dos Santos","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.007_bb0965","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biomaterials.2019.05.012","article-title":"Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis","volume":"212","author":"Gou","year":"2019","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.jconrel.2023.08.007_bb0970","article-title":"Colon-targeted adhesive hydrogel microsphere for regulation of gut immunity and flora","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb0975","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/acsptsci.9b00037","article-title":"Antibody-mediated delivery of VEGFC ameliorates experimental chronic colitis","volume":"2","author":"Tacconi","year":"2019","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"10","key":"10.1016\/j.jconrel.2023.08.007_bb0980","first-page":"666","article-title":"A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory \u2018armed antibody\u2019 for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate","volume":"16","author":"Galeazzi","year":"2014","journal-title":"Isr. Med. Assoc. J."},{"issue":"8","key":"10.1016\/j.jconrel.2023.08.007_bb0985","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/MIB.0000000000000440","article-title":"Alternatively spliced EDA domain of fibronectin is a target for pharmacodelivery applications in inflammatosry bowel disease","volume":"21","author":"Bootz","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"9","key":"10.1016\/j.jconrel.2023.08.007_bb0990","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044328","article-title":"Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation","volume":"7","author":"Chassaing","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jconrel.2023.08.007_bb0995","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1097\/MIB.0000000000000851","article-title":"Antibody-based targeted delivery of interleukin-22 promotes rapid clinical recovery in mice with DSS-induced colitis","volume":"22","author":"Bootz","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"issue":"10","key":"10.1016\/j.jconrel.2023.08.007_bb1000","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1039\/C9BM00925F","article-title":"A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitis","volume":"7","author":"Wu","year":"2019","journal-title":"Biomater. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2023.08.007_bb1005","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ymthe.2016.11.020","article-title":"Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis","volume":"25","author":"Xiao","year":"2017","journal-title":"Mol. Ther."},{"issue":"48","key":"10.1016\/j.jconrel.2023.08.007_bb1010","doi-asserted-by":"crossref","first-page":"33665","DOI":"10.1074\/jbc.M804067200","article-title":"Carbohydrate binding mechanism of the macrophage galactose-type C-type lectin 1 revealed by saturation transfer experiments","volume":"283","author":"Sakakura","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb1015","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1016\/j.actbio.2012.11.007","article-title":"Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization","volume":"9","author":"Wang","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biomaterials.2018.09.005","article-title":"Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease","volume":"185","author":"Date","year":"2018","journal-title":"Biomaterials"},{"issue":"32","key":"10.1016\/j.jconrel.2023.08.007_bb1025","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1039\/C9TB00957D","article-title":"Disassembling the complexity of mucus barriers to develop a fast screening tool for early drug discovery","volume":"7","author":"Pacheco","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biomaterials.2018.06.015","article-title":"Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors","volume":"178","author":"Gan","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addr.2020.07.010","article-title":"Advanced nanomedicines for the treatment of inflammatory diseases","volume":"157","author":"Brusini","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"38","key":"10.1016\/j.jconrel.2023.08.007_bb1040","doi-asserted-by":"crossref","first-page":"14581","DOI":"10.1039\/C7NR04734G","article-title":"Engineered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases","volume":"9","author":"Corbo","year":"2017","journal-title":"Nanoscale"},{"issue":"9","key":"10.1016\/j.jconrel.2023.08.007_bb1045","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nmat4644","article-title":"Biomimetic proteolipid vesicles for targeting inflamed tissues","volume":"15","author":"Molinaro","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2019.02.034","article-title":"Ulcerative colitis-specific delivery of keratinocyte growth factor by neutrophils-simulated liposomes facilitates the morphologic and functional recovery of the damaged colon through alleviating the inflammation","volume":"299","author":"Zhao","year":"2019","journal-title":"J. Control. Release"},{"issue":"22","key":"10.1016\/j.jconrel.2023.08.007_bb1055","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.7150\/thno.48448","article-title":"Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-230X-14-68","article-title":"Mucosal gene therapy using a pseudotyped lentivirus vector encoding murine interleukin-10 (mIL-10) suppresses the development and relapse of experimental murine colitis","volume":"14","author":"Matsumoto","year":"2014","journal-title":"BMC Gastroenterol."},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb1065","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0016-5085(03)00262-2","article-title":"A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model","volume":"124","author":"Katayama","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb1070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/mt.2013.214","article-title":"Targeting intestinal inflammation with CD98 siRNA\/PEI-loaded nanoparticles","volume":"22","author":"Laroui","year":"2014","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb1075","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/gut.2009.184556","article-title":"Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis","volume":"59","author":"Zuo","year":"2010","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb1080","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1039\/D0BM01359E","article-title":"Nanoparticle-mediated gene therapy strategies for mitigating inflammatory bowel disease","volume":"9","author":"Verma","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.jconrel.2023.08.007_bb1090","doi-asserted-by":"crossref","first-page":"18653","DOI":"10.1021\/acsnano.1c09951","article-title":"Nanoencapsulation for probiotic delivery","volume":"15","author":"Centurion","year":"2021","journal-title":"ACS Nano"},{"issue":"Pt 1","key":"10.1016\/j.jconrel.2023.08.007_bb1095","article-title":"Polysaccharides, proteins, and their complex as microencapsulation carriers for delivery of probiotics: a review on carrier types and encapsulation techniques","volume":"242","author":"Xie","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.jconrel.2023.08.007_bb1100","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1021\/acsnano.3c00600","article-title":"Bacteria-induced colloidal encapsulation for probiotic oral delivery","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.msec.2018.12.127","article-title":"Fabrication of alginate-based stimuli-responsive, non-cytotoxic, terpolymric semi-IPN hydrogel as a carrier for controlled release of bovine albumin serum and 5-amino salicylic acid","volume":"98","author":"Das","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1110","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jconrel.2022.12.029","article-title":"Colonic drug delivery: formulating the next generation of colon-targeted therapeutics","volume":"353","author":"McCoubrey","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2019.11.001","article-title":"Inflammation-triggered local drug release ameliorates colitis by inhibiting dendritic cell migration and Th1\/Th17 differentiation","volume":"316","author":"Regmi","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1120","first-page":"11 (3)","article-title":"Evaluation of a methylcellulose and hyaluronic acid hydrogel as a vehicle for rectal delivery of biologics","author":"Aprodu","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2023.08.007_bb1125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2015.04.002","article-title":"A thermo-sensitive delivery platform for topical administration of inflammatory bowel disease therapies","volume":"149","author":"Sinha","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110252","article-title":"New tools to design smart thermosensitive hydrogels for protein rectal delivery in IBD","volume":"106","author":"Garcia-Del Rio","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119846","article-title":"Temperature-sensitive hydrogel for rectal perfusion improved the therapeutic effect of Kangfuxin liquid on DSS-induced ulcerative colitis mice: The inflammation alleviation and the colonic mucosal barriers repair","volume":"589","author":"Xue","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.colsurfb.2015.03.002","article-title":"Systemic modulation of the stability of pluronic hydrogel by a small amount of graphene oxide","volume":"128","author":"Won","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.129221","article-title":"Thermo-sensitive hydrogel with mussel-inspired adhesion enhanced the non-fibrotic repair effect of EGF on colonic mucosa barrier of TNBS-induced ulcerative colitis rats through macrophage polarizing","volume":"416","author":"Wang","year":"2021","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actbio.2020.04.034","article-title":"Dual dynamically crosslinked thermosensitive hydrogel with self-fixing as a postoperative anti-adhesion barrier","volume":"110","author":"Li","year":"2020","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.jconrel.2023.08.007_bb1155","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1080\/03639045.2018.1483393","article-title":"Pluronic lecithin organogel of 5-aminosalicylic acid for wound healing","volume":"44","author":"Sanapalli","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.carbpol.2015.04.063","article-title":"Injectable thermosensitive chitosan hydrogels with controlled gelation kinetics and enhanced mechanical resistance","volume":"130","author":"Assaad","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1165","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.carbpol.2014.09.094","article-title":"Glycerophosphate-based chitosan thermosensitive hydrogels and their biomedical applications","volume":"117","author":"Zhou","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1170","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109870","article-title":"Development of chitosan\/glycerophosphate\/collagen thermo-sensitive hydrogel for endoscopic treatment of mucosectomy-induced ulcer","volume":"103","author":"Shan","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"18","key":"10.1016\/j.jconrel.2023.08.007_bb1175","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1039\/D1TB00499A","article-title":"Thermosensitive polymer hydrogel as a physical shield on colonic mucosa for colitis treatment","volume":"9","author":"Guo","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"6515","key":"10.1016\/j.jconrel.2023.08.007_bb1180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aay7367","article-title":"Proximal colon-derived O-glycosylated mucus encapsulates and modulates the microbiota","volume":"370","author":"Bergstrom","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1185","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.actbio.2016.10.026","article-title":"Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis","volume":"48","author":"Xu","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1190","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.carbpol.2016.10.012","article-title":"Chitosan hydrogel formation using laccase activated phenolics as cross-linkers","volume":"157","author":"Huber","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1195","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jcis.2018.10.056","article-title":"pH-responsive injectable hydrogels with mucosal adhesiveness based on chitosan-grafted-dihydrocaffeic acid and oxidized pullulan for localized drug delivery","volume":"536","author":"Liang","year":"2019","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.actbio.2022.02.039","article-title":"A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon","volume":"143","author":"Yingzheng Zhao","year":"2022","journal-title":"Acta Biomater."},{"issue":"300","key":"10.1016\/j.jconrel.2023.08.007_bb1205","doi-asserted-by":"crossref","first-page":"300ra128","DOI":"10.1126\/scitranslmed.aaa5657","article-title":"An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2014.12.012","article-title":"Amphiphilic poly(amino acid) based micelles applied to drug delivery: the in vitro and in vivo challenges and the corresponding potential strategies","volume":"199","author":"Xu","year":"2015","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb1215","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1039\/C9BM00341J","article-title":"Thiolated gamma-polyglutamic acid as a bioadhesive hydrogel-forming material: evaluation of gelation, bioadhesive properties and sustained release of KGF in the repair of injured corneas","volume":"7","author":"Xu","year":"2019","journal-title":"Biomater. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2023.08.007_bb1220","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1021\/acsbiomaterials.1c00792","article-title":"Self-cross-linked hydrogel of cysteamine-grafted gamma-polyglutamic acid stabilized tripeptide KPV for alleviating TNBS-induced ulcerative colitis in rats","volume":"7","author":"Sun","year":"2021","journal-title":"Acs Biomater. Sci. Eng."},{"issue":"9","key":"10.1016\/j.jconrel.2023.08.007_bb1225","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41563-018-0106-5","article-title":"Therapeutic luminal coating of the intestine","volume":"17","author":"Lee","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21037\/tgh.2020.02.02","article-title":"Barrier therapies supporting the biology of the mucosal barrier-medical devices for common clinical mucosal disorders","volume":"6","author":"McCullough","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"49","key":"10.1016\/j.jconrel.2023.08.007_bb1235","doi-asserted-by":"crossref","first-page":"58340","DOI":"10.1021\/acsami.1c17706","article-title":"Design strategy for a hydroxide-triggered pH-responsive hydrogel as a mucoadhesive barrier to prevent metabolism disorders","volume":"13","author":"Tang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"16","key":"10.1016\/j.jconrel.2023.08.007_bb1240","doi-asserted-by":"crossref","first-page":"18225","DOI":"10.1021\/acsami.9b22120","article-title":"Dopamine-modified hyaluronic acid hydrogel adhesives with fast-forming and high tissue adhesion","volume":"12","author":"Zhou","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.jconrel.2023.08.007_bb1245","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1021\/acsnano.7b08969","article-title":"Polyphenol-binding amyloid fibrils self-assemble into reversible hydrogels with antibacterial activity","volume":"12","author":"Hu","year":"2018","journal-title":"ACS Nano"},{"issue":"13","key":"10.1016\/j.jconrel.2023.08.007_bb1250","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1016\/j.biomaterials.2010.01.063","article-title":"The adhesive properties of coacervated recombinant hybrid mussel adhesive proteins","volume":"31","author":"Lim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1255","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.actbio.2019.01.007","article-title":"Prolonged cell persistence with enhanced multipotency and rapid angiogenesis of hypoxia pre-conditioned stem cells encapsulated in marine-inspired adhesive and immiscible liquid micro-droplets","volume":"86","author":"Park","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1260","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jconrel.2020.02.047","article-title":"Stem cell-loaded adhesive immiscible liquid for regeneration of myocardial infarction","volume":"321","author":"Park","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1265","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biomaterials.2016.11.017","article-title":"A biomaterial-assisted mesenchymal stromal cell therapy alleviates colonic radiation-induced damage","volume":"115","author":"Moussa","year":"2017","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jconrel.2023.08.007_bb1270","first-page":"360","article-title":"Restoring mucosal barrier function and modifying macrophage phenotype with an extracellular matrix hydrogel: potential therapy for ulcerative colitis","volume":"11","author":"Keane","year":"2017","journal-title":"J. Crohns. Colitis."},{"issue":"23","key":"10.1016\/j.jconrel.2023.08.007_bb1275","article-title":"Mesenchymal stem cell capping on ECM-anchored caspase inhibitor-loaded PLGA microspheres for intraperitoneal injection in DSS-induced murine colitis","volume":"15","author":"Pathak","year":"2019","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.jconrel.2023.08.007_bb1280","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/bip.360340508","article-title":"Unusually stable beta-sheet formation in an ionic self-complementary oligopeptide","volume":"34","author":"Zhang","year":"1994","journal-title":"Biopolymers"},{"issue":"6","key":"10.1016\/j.jconrel.2023.08.007_bb1285","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.gie.2015.11.015","article-title":"A novel fully synthetic and self-assembled peptide solution for endoscopic submucosal dissection-induced ulcer in the stomach","volume":"83","author":"Uraoka","year":"2016","journal-title":"Gastrointest. Endosc."},{"issue":"9","key":"10.1016\/j.jconrel.2023.08.007_bb1290","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/ecco-jcc\/jjab033","article-title":"Therapeutic potential of a self-assembling peptide hydrogel to treat colonic injuries associated with inflammatory bowel disease","volume":"15","author":"Araki","year":"2021","journal-title":"J. Crohns. Colitis."},{"issue":"11","key":"10.1016\/j.jconrel.2023.08.007_bb1295","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ncb3632","article-title":"Synthetic hydrogels for human intestinal organoid generation and colonic wound repair","volume":"19","author":"Cruz-Acuna","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.08.007_bb1300","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120377","article-title":"Enhanced stem cell retention and antioxidative protection with injectable, ROS-degradable PEG hydrogels","volume":"263","author":"Martin","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.08.007_bb1305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120125","article-title":"Fully synthetic matrices for in vitro culture of primary human intestinal enteroids and endometrial organoids","volume":"254","author":"Hernandez-Gordillo","year":"2020","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.jconrel.2023.08.007_bb1310","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1016\/j.biomaterials.2003.10.045","article-title":"Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds","volume":"25","author":"Awad","year":"2004","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.jconrel.2023.08.007_bb1315","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0142-9612(02)00635-X","article-title":"A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering","volume":"24","author":"Yoshimoto","year":"2003","journal-title":"Biomaterials"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:43:11Z","timestamp":1777509791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923005035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":263,"alternative-id":["S0168365923005035"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.007","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}